首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Accounting for treatment by center interaction in sample size determinations and the use of surrogate outcomes in the pessary for the prevention of preterm birth trial: a simulation study
【2h】

Accounting for treatment by center interaction in sample size determinations and the use of surrogate outcomes in the pessary for the prevention of preterm birth trial: a simulation study

机译:在样本量确定中通过中心相互作用进行治疗以及在子宫托中使用替代结局预防早产试验的考虑:模拟研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe Pessary for the Prevention of Preterm Birth Study (PS3) is an international, multicenter, randomized clinical trial designed to examine the effectiveness of the Arabin pessary in preventing preterm birth in pregnant women with a short cervix. During the design of the study two methodological issues regarding power and sample size were raised. Since treatment in the Standard Arm will vary between centers, it is anticipated that so too will the probability of preterm birth in that arm. This will likely result in a treatment by center interaction, and the issue of how this will affect the sample size requirements was raised. The sample size requirements to examine the effect of the pessary on the baby’s clinical outcome was prohibitively high, so the second issue is how best to examine the effect on clinical outcome. The approaches taken to address these issues are presented.
机译:背景预防早产子宫托研究(PS3)是一项国际性,多中心,随机临床试验,旨在检查阿拉伯蛋白子宫托在预防子宫颈短的孕妇中早产的有效性。在研究的设计中,提出了关于功效和样本量的两个方法学问题。由于标准臂的治疗在各个中心之间会有所不同,因此预计该臂早产的可能性也会有所不同。这很可能会导致中心互动进行治疗,并提出了如何影响样本量要求的问题。检查子宫托对婴儿临床结局影响的样本量要求过高,因此第二个问题是如何最好地检查对子宫结局的影响。提出了解决这些问题的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号